Shanghai Serum Bio-technology Co., Ltd. Class ASSE: 688163

"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Voluntary Disclosure of Receipt of the Certificate of GMP Compliance from the Philippines

Sep 25, 2026 · Issued by Shanghai Serum Bio-technology Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 25, 2026

Announcement on Voluntary Disclosure of Receipt of the Certificate of GMP Compliance from the Philippines

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Shanghai Serum Bio-technology Co., Ltd. Class A

"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Departure of a Director, Senior Management Member and Core Technical Personnel, By-election of a Director and Adjustment of Core Technical PersonnelSep 12
"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 9
"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO IndustrySep 4
"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on the Profit Distribution Plan for the First Half of 2026Aug 22

All Shanghai Serum Bio-technology Co., Ltd. Class A news releases